ALYREF and breast carcinoma: As shown in Figure 1B, expression of NSUN1, NSUN2, NSUN5, DNMT1, DNMT3A, DNMT3B, and ALYREF was significantly increased, but DNMT2 and TET2 expression was markedly decreased in breast cancer tissues when compared with normal breast tissues.